Skip to content

AbbVie ABBV Finished goods

Finished goods at other companies

Pfizer logo
PfizerPFE
Amgen logo
AmgenAMGN
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
Incyte logo
IncyteINCY
Establishment Labs logo
Establishment LabsESTA
The Beauty Health Company logo
The Beauty Health CompanySKIN

Other financials

Income statement

See full
Revenue$15.0B+12.4%
Gross profit$10.8B+15.4%
Operating income$4.0B+6.9%
Net income$695.0M-46.0%
EPS (diluted)$0.39-45.8%

Balance sheet

See full
Cash & equivalents$9.4B+81.5%
Total debt$62.4B+1.8%
Total equity-$6.7B-569%
Total assets$136.46B+0.2%

Cash flow

See full
Operating cash flow$3.8B+134%
CapEx$265.0M+12.8%
Free cash flow$3.6B+155%

Valuation

See full
Market cap$444.6B+39.8%
P/E122.3×+37.8×
P/S7.1×+1.6×

Profitability

See full
Gross margin70.7%0.0pp
Operating margin24.4%
Net margin5.8%-1.5pp
FCF margin31.8%+5.0pp

Returns & leverage

See full
Return on equity89%+32.7pp
Debt / equity46.6×+38.6×
Current ratio0.8×0.0×

Where this comes from

Reported directly by AbbVie in its filing.

Tagged under the XBRL concept us-gaap:InventoryFinishedGoodsNetOfReserves.

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's finished goods.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbbVie's finished goods?
AbbVie (ABBV) reported finished goods of $1.81B in Q1 2026.
How has AbbVie's finished goods changed year-over-year?
AbbVie's finished goods increased by 25.3% year-over-year, from $1.44B to $1.81B.
What is the long-term trend for AbbVie's finished goods?
Over 5 years (2020 to 2025), AbbVie's finished goods has grown at a 3.7% compound annual growth rate (CAGR), from $1.32B to $1.58B.